Zhonghan Zhang

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 6

Top Topics

Small Cell Lung Cancer

Tyrosine Kinase

Radiation Therapy

Top Venues

International journal of cancer

Journal of hematology & oncology

Cancer communications (London, England)

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zhonghan Zhang, Fan Luo, Jiaxin Cao, Feiteng Lu, Yang Zhang, Yuxiang Ma, Kangmei Zeng, Li Zhang, Hongyun Zhao
Anticancer bispecific antibody R&D advances: a study focusing on research trend worldwide and in China. Journal of hematology & oncology 14 (1) (2021)
Zhonghan Zhang, Yang Zhang, Fan Luo, Yuxiang Ma, Wenfeng Fang, Jing Zhan, Su Li, Yunpeng Yang, Yuanyuan Zhao, Shaodong Hong, Ting Zhou, Yaxiong Zhang, Shen Zhao, Yan Huang, Hongyun Zhao, Li Zhang
Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first-line treatment for advanced EGFR-mutant non-small cell lung cancer. Clinical and translational medicine 10 (2) (2020)
Shen Zhao, Zhonghan Zhang, Yaxiong Zhang, Shaodong Hong, Ting Zhou, Yunpeng Yang, Wenfeng Fang, Hongyun Zhao, Li Zhang
Progression-free survival and one-year milestone survival as surrogates for overall survival in previously treated advanced non-small cell lung cancer. International journal of cancer 144 (11) (2019)
Zhonghan Zhang, Fan Luo, Yang Zhang, Yuxiang Ma, Shaodong Hong, Yunpeng Yang, Wenfeng Fang, Yan Huang, Li Zhang, Hongyun Zhao
The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706). Cancer communications (London, England) 39 (1) (2019)
Zhonghan Zhang, Yaxiong Zhang, Gang Chen, Shaodong Hong, Yunpeng Yang, Wenfeng Fang, Fan Luo, Xi Chen, Yuxiang Ma, Yuanyuan Zhao, Jianhua Zhan, Cong Xue, Xue Hou, Ting Zhou, Shuxiang Ma, Fangfang Gao, Yan Huang, Likun Chen, Ningning Zhou, Hongyun Zhao, Li Zhang
Olanzapine-Based Triple Regimens Versus Neurokinin-1 Receptor Antagonist-Based Triple Regimens in Preventing Chemotherapy-Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta-Analysis. The oncologist 23 (5) (2018)
Shen Zhao, Fangfang Gao, Yaxiong Zhang, Zhonghan Zhang, Li Zhang
Bevacizumab in combination with different platinum-based doublets in the first-line treatment for advanced nonsquamous non-small-cell lung cancer: A network meta-analysis. International journal of cancer 142 (8) (2017)